Enoxaparin reduces adrenergic contraction of resistance arterioles in aging and in aging associated with diabetes via engagement of MAP kinase pathway.
about
Enoxaparin reduces adrenergic contraction of resistance arterioles in aging and in aging associated with diabetes via engagement of MAP kinase pathway.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Enoxaparin reduces adrenergic ...... agement of MAP kinase pathway.
@en
Enoxaparin reduces adrenergic ...... agement of MAP kinase pathway.
@nl
type
label
Enoxaparin reduces adrenergic ...... agement of MAP kinase pathway.
@en
Enoxaparin reduces adrenergic ...... agement of MAP kinase pathway.
@nl
prefLabel
Enoxaparin reduces adrenergic ...... agement of MAP kinase pathway.
@en
Enoxaparin reduces adrenergic ...... agement of MAP kinase pathway.
@nl
P2093
P1476
Enoxaparin reduces adrenergic ...... agement of MAP kinase pathway.
@en
P2093
Doina Popov
Irina Titorencu
Miruna Nemecz
Nicoleta Alexandru
P304
P356
10.1097/MBC.0B013E328345123D
P577
2011-06-01T00:00:00Z